Shengze Zhang

Dr. Shengze Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2024 in EBioMedicine
Verified
Journal Article
Open access
LYLifang Yuan
Lifang Yuan
SZShengze Zhang
Shengze Zhang
RBRongjun Bi
Rongjun Bi
LXLiu Xuejie
Liu Xuejie
ZHZirong Han
Zirong Han
YSYuelong Shu
Yuelong Shu
Influenza viruses pose a persistent threat to global public health, necessitating the development of innovative and broadly effective vaccines. This study focuses on a multiepitope vaccine (MEV) designed to provide broad-spectrum protection against different influenza viruses. The MEV, containing 19 B-cell linear epitopes, 7 CD4+ T cells, and 11 CD8+ T cells epitopes identified through enzyme-linked immunospot assay (ELISPOT) in influenza viruses infected mice, was administered through a regimen of two doses of DNA vaccine followed by one dose of a protein vaccine in C57BL/6 female mice. Upon lethal challenge with both seasonal circulating strains (H1N1, H3N2, BV, and BY) and historical strains (H1N1-PR8 and H3N2-X31), MEV demonstrated substantial protection against different influenza seasonal strains, with partial efficacy against historical strains. Notably, the increased germinal centre B cells and antibody-secreting cells, along with robust T cell immune responses, highlighted the comprehensive immune defence elicited by MEV. Elevated hemagglutinin inhibition antibody was also observed against seasonal circulating and historical strains. Additionally, mice vaccinated with MEV exhibited significantly lower counts of inflammatory cells in the lungs compared to negative control groups. Our results demonstrated the efficacy of a broad-spectrum MEV against influenza viruses in mice. Conducting long-term studies to evaluate the durability of MEV-induced immune responses and explore its potential application in diverse populations will offer valuable insights for the continued advancement of this promising vaccine. Funding bodies are described in the Acknowledgments section.

31 October 2024 in Viruses
Verified
Journal Article
Open access
PDF file
TXTing Xie
Ting Xie
QCQiqi Chen
Qiqi Chen
NLNina Li
Nina Li
SZShengze Zhang
Shengze Zhang
LZLin Zhu
Lin Zhu
Huanle LuoHuanle Luo
Huanle Luo
The FADD-like interleukin-1β converting enzyme (FLICE)-inhibitory protein (c-FLIP) plays a crucial role in various biological processes, including apoptosis and inflammation. However, the complete transcriptional profile altered by the c-FLIP is not fully understood. Furthermore, the impact of the c-FLIP deficiency on the transcriptome during a Zika virus (ZIKV) infection, which induces apoptosis and inflammation in the central nervous system (CNS), has not yet been elucidated. In this study, we compared transcriptome profiles between wild-type (WT) and the c-Flip heterozygous knockout mice (c-Flip+/−) fetal heads at embryonic day 13.5 from control and PBS-infected WT dams mated with c-Flip+/− sires. In the non-infected group, we observed differentially expressed genes (DEGs) mainly involved in embryonic development and neuron development. However, the ZIKV infection significantly altered the transcriptional profile between WT and the c-Flip+/− fetal heads. DEGs in pattern recognition receptor (PRR)-related signaling pathways, such as the RIG-I-like receptor signaling pathway and Toll-like receptor signaling pathway, were enriched. Moreover, the DEGs were also enriched in T cells, indicating that the c-FLIP participates in both innate and adaptive immune responses upon viral infection. Furthermore, our observations indicate that DEGs are associated with sensory organ development and eye development, suggesting a potential role for the c-FLIP in ZIKV-induced organ development defects. Overall, we have provided a comprehensive transcriptional profile for the c-FLIP and its modulation during a ZIKV infection.

2 November 2026 in Viruses
Verified
Journal Article
Open access
PDF file
SZShengze Zhang
Shengze Zhang
Huanle LuoHuanle Luo
Huanle Luo
GLGuodong Liang
Guodong Liang
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus and the leading cause of viral encephalitis in many regions of Asia. Owing to its pronounced neurotropism, JEV infection can result in severe neurological disease with high mortality, while 30–50% of survivors develop permanent neurological sequelae. Although substantial progress has been made over the past few decades, the molecular mechanisms underlying JEV infection, neuroinvasion, and host-mediated pathogenesis remain incompletely understood. In this review, we summarize recent advances in the understanding of JEV pathogenesis from both viral and host perspectives. We discuss the key events during JEV infection in mammalian hosts, including viral attachment and entry, replication and dissemination, viral determinants of virulence, blood–brain barrier penetration, and the mechanisms underlying central and peripheral nervous system injury. We further compare currently available experimental models for JEV research, including mouse models, porcine models, and human brain organoid systems, highlighting their respective applications, advantages, and limitations in investigating JEV pathogenesis. Collectively, this review provides an integrated overview of the molecular and cellular mechanisms governing JEV infection and neuropathogenesis, identifies current knowledge gaps, and discusses future research priorities that may facilitate the development of effective antiviral and neuroprotective strategies against Japanese encephalitis.